Capital Research Global Investors

Capital Research Global Investors Portfolio holdings

AUM $499B
 

Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.

This Quarter Return
+12.56%
1 Year Return
+30.87%
3 Year Return
+131.94%
5 Year Return
+208.22%
10 Year Return
+564.75%
AUM
$442B
AUM Growth
+$442B
Cap. Flow
-$4.01B
Cap. Flow %
-0.91%
Top 10 Hldgs %
32.32%
Holding
435
New
27
Increased
175
Reduced
154
Closed
25

Sector Composition

1 Technology 25.54%
2 Healthcare 15.36%
3 Industrials 13.38%
4 Consumer Discretionary 12.48%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RIO icon
426
Rio Tinto
RIO
$102B
-3,714 Closed -$277K
RIVN icon
427
Rivian
RIVN
$16.5B
-1,124,344 Closed -$26.4M
SBAC icon
428
SBA Communications
SBAC
$22B
-456,515 Closed -$116M
HTO
429
H2O America Common Stock
HTO
$1.78B
-242,255 Closed -$15.8M
STT icon
430
State Street
STT
$32.6B
-602,643 Closed -$46.7M
VXUS icon
431
Vanguard Total International Stock ETF
VXUS
$102B
-5,364 Closed -$311K
WDS icon
432
Woodside Energy
WDS
$32.6B
-87,502 Closed -$1.85M
RYZB
433
DELISTED
RayzeBio, Inc. Common Stock
RYZB
-170,808 Closed -$10.6M
LTHM
434
DELISTED
Livent Corporation
LTHM
-7,433,396 Closed -$134M
INBX
435
DELISTED
Inhibrx, Inc. Common Stock
INBX
-712,360 Closed -$27.1M